These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18045863)

  • 1. Comprehensive analysis of the factors contributing to the stability and solubility of autonomous human VH domains.
    Barthelemy PA; Raab H; Appleton BA; Bond CJ; Wu P; Wiesmann C; Sidhu SS
    J Biol Chem; 2008 Feb; 283(6):3639-3654. PubMed ID: 18045863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of CDR3 to V H H domain stability and the design of monobody scaffolds for naive antibody libraries.
    Bond CJ; Marsters JC; Sidhu SS
    J Mol Biol; 2003 Sep; 332(3):643-55. PubMed ID: 12963373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Engineering of Optimized Autonomous Heavy-Chain Variable Domains.
    Nilvebrant J; Ereño-Orbea J; Gorelik M; Julian MC; Tessier PM; Julien JP; Sidhu SS
    J Mol Biol; 2021 Oct; 433(21):167241. PubMed ID: 34508727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fully Human VH Single Domains That Rival the Stability and Cleft Recognition of Camelid Antibodies.
    Rouet R; Dudgeon K; Christie M; Langley D; Christ D
    J Biol Chem; 2015 May; 290(19):11905-17. PubMed ID: 25737448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a large phage-displayed human antibody domain library with a scaffold based on a newly identified highly soluble, stable heavy chain variable domain.
    Chen W; Zhu Z; Feng Y; Xiao X; Dimitrov DS
    J Mol Biol; 2008 Oct; 382(3):779-89. PubMed ID: 18687338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biophysical properties of human antibody variable domains.
    Ewert S; Huber T; Honegger A; Plückthun A
    J Mol Biol; 2003 Jan; 325(3):531-53. PubMed ID: 12498801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine IgM antibodies with exceptionally long complementarity-determining region 3 of the heavy chain share unique structural properties conferring restricted VH + Vlambda pairings.
    Saini SS; Farrugia W; Ramsland PA; Kaushik AK
    Int Immunol; 2003 Jul; 15(7):845-53. PubMed ID: 12807823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structure-based database of antibody variable domain diversity.
    Bond CJ; Wiesmann C; Marsters JC; Sidhu SS
    J Mol Biol; 2005 May; 348(3):699-709. PubMed ID: 15826665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold.
    Jespers L; Schon O; James LC; Veprintsev D; Winter G
    J Mol Biol; 2004 Apr; 337(4):893-903. PubMed ID: 15033359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biophysical properties of camelid V(HH) domains compared to those of human V(H)3 domains.
    Ewert S; Cambillau C; Conrath K; Plückthun A
    Biochemistry; 2002 Mar; 41(11):3628-36. PubMed ID: 11888279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of synthetic autonomous VH domain libraries and structural analysis of a VH domain bound to vascular endothelial growth factor.
    Ma X; Barthelemy PA; Rouge L; Wiesmann C; Sidhu SS
    J Mol Biol; 2013 Jun; 425(12):2247-59. PubMed ID: 23507309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A large human domain antibody library combining heavy and light chain CDR3 diversity.
    Chen W; Zhu Z; Feng Y; Dimitrov DS
    Mol Immunol; 2010 Jan; 47(4):912-21. PubMed ID: 19883941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving solubility and refolding efficiency of human V(H)s by a novel mutational approach.
    Tanha J; Nguyen TD; Ng A; Ryan S; Ni F; Mackenzie R
    Protein Eng Des Sel; 2006 Nov; 19(11):503-9. PubMed ID: 16971398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directed evolution of human heavy chain variable domain (VH) using in vivo protein fitness filter.
    Kim DS; Song HN; Nam HJ; Kim SG; Park YS; Park JC; Woo EJ; Lim HK
    PLoS One; 2014; 9(6):e98178. PubMed ID: 24892548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.
    Sidhu SS; Li B; Chen Y; Fellouse FA; Eigenbrot C; Fuh G
    J Mol Biol; 2004 Apr; 338(2):299-310. PubMed ID: 15066433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features.
    Harmsen MM; Ruuls RC; Nijman IJ; Niewold TA; Frenken LG; de Geus B
    Mol Immunol; 2000 Aug; 37(10):579-90. PubMed ID: 11163394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfide linkage engineering for improving biophysical properties of human VH domains.
    Kim DY; Kandalaft H; Ding W; Ryan S; van Faassen H; Hirama T; Foote SJ; MacKenzie R; Tanha J
    Protein Eng Des Sel; 2012 Oct; 25(10):581-9. PubMed ID: 22942392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single domain camel antibodies: current status.
    Muyldermans S
    J Biotechnol; 2001 Jun; 74(4):277-302. PubMed ID: 11526908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain.
    Riechmann L
    J Mol Biol; 1996 Jun; 259(5):957-69. PubMed ID: 8683598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments.
    Ichiyoshi Y; Casali P
    J Exp Med; 1994 Sep; 180(3):885-95. PubMed ID: 8064239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.